From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...

In February, Takeda signed an MoU on rare diseases with the Medical Services Administration under the Ministry of Health, in ...

Effective dengue prevention requires a combination of vector control and vaccination efforts, a group of physicians said ...

Across California, public health and pest control authorities are facing a new reality as the Aedes mosquitoes bring the ...

Climate change and mosquitos are creating an epidemic of dengue in Oaxaca, as researchers work to counteract the disease.

People infected a second time are at especially high risk. There is no specific medication to treat dengue. Japanese ...

With dengue fever spreading to colder climates, Island Pharmaceuticals is working on a preventative and therapeutic solution.

A dengue vaccine is available in the U.S. and is approved by the U.S. Food and Drug Administration for children between ages 9 and 16 who have a laboratory-confirmed previous dengue virus ...

Dr. Nina Gloriani, Head of the Department of Science and Technology’s (DOST) Vaccine Expert Panel, highlighted the cyclical nature of dengue and the increasing morbidity rates. “We’ve seen ...

All growth rates mentioned below are on a year-on-year basis and at CER. Sanofi’s Biopharma segment includes Pharma and Vaccines. Biopharma sales rose 16.6% in the quarter to €12.17 billion. Pharma ...

The pharmaceutical company reported third-quarter earnings and sales that beat analysts’ expectations, boosted by ...